Group One Trading, L.P. Oramed Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 100 shares of ORMP stock, worth $237. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 9,188 98.91%

Holding current value

$237

Previous $23,000 100.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.21 - $2.63 $20,084 - $23,901	-9,088 Reduced 98.91%	100 $0
Q2 2024 Aug 14, 2024	SELL	$2.07 - $2.83 $20,300 - $27,753	-9,807 Reduced 51.63%	9,188 $23,000
Q1 2024 May 10, 2024	BUY	$2.18 - $3.58 $18,748 - $30,788	8,600 Added 82.73%	18,995 $55,000
Q4 2023 Feb 14, 2024	SELL	$1.71 - $2.57 $171 - $257	-100 Reduced 0.95%	10,395 $24,000
Q3 2023 Nov 09, 2023	BUY	$2.51 - $3.55 $26,342 - $37,257	10,495 New	10,495 $27,000
Q4 2022 Feb 09, 2023	BUY	$5.88 - $12.03 $369,910 - $756,807	62,910 Added 160.66%	102,067 $1.23 Million
Q3 2022 Nov 09, 2022	BUY	$4.6 - $9.91 $143,202 - $308,508	31,131 Added 387.88%	39,157 $254,000
Q2 2022 Aug 11, 2022	BUY	$3.72 - $9.0 $29,856 - $72,234	8,026 New	8,026 $37,000
Q1 2022 May 12, 2022	SELL	$8.19 - $13.89 $46,314 - $78,547	-5,655 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$12.98 - $29.75 $36,590 - $83,865	-2,819 Reduced 33.27%	5,655 $81,000
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $67,091 - $131,748	5,531 Added 187.94%	8,474 $186,000
Q2 2021 Aug 10, 2021	BUY	$8.34 - $14.59 $24,544 - $42,938	2,943 New	2,943 $39,000
Q4 2020 Feb 10, 2021	SELL	$2.48 - $4.64 $880 - $1,647	-355 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.58 - $4.16 $915 - $1,476	355 New	355 $1,000
Q1 2019 May 13, 2019	SELL	$2.95 - $3.64 $49,855 - $61,516	-16,900 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$4.64 - $7.11 $78,416 - $120,159	16,900 New	16,900 $82,000
Q1 2018 May 11, 2018	SELL	$6.51 - $9.14 $74,715 - $104,899	-11,477 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.95 - $11.15 $30,782 - $43,172	3,872 Added 50.91%	11,477 $103,000
Q3 2017 Nov 15, 2017	BUY	$7.74 - $10.78 $43,382 - $60,421	5,605 Added 280.25%	7,605 $75,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,000	2,000 $16,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.4M

Call Options Held

Put Options Held

2.1K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Oramed Pharmaceuticals Inc. Transaction History